ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,355.50
-18.00 (-1.31%)
Last Updated: 14:06:01
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -18.00 -1.31% 1,355.50 1,355.00 1,355.50 1,368.00 1,353.50 1,364.00 1,700,592 14:06:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.42 56.93B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,373.50p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £56.93 billion. Gsk has a price to earnings ratio (PE ratio) of 11.42.

Gsk Share Discussion Threads

Showing 30851 to 30872 of 34100 messages
Chat Pages: Latest  1244  1243  1242  1241  1240  1239  1238  1237  1236  1235  1234  1233  Older
DateSubjectAuthorDiscuss
15/8/2022
20:02
so what do they think now after the latest ex-pose i wonder?
lippy4
15/8/2022
19:20
This is worth reading. It is teh letter from Elliot advisors over why they took their £3bln stake in the company.
berny3
15/8/2022
17:58
Whats the forecast yield for gsk
coxsmn
15/8/2022
15:43
strange this did not happen before splitting the company???
lippy4
15/8/2022
15:02
Looks like litigation and short story running out of steam.....

Next stop is a rise......

Unless there is more litigation news - dont hold your breath - it will be a long wait.

netcurtains
15/8/2022
14:55
Don't be fooled into this Risky level. The worry will carry on and increase as trials in Illinois are due to begin on 22 August. Remember GSK can fall quickly as further bad news in the pipeline as claims against GSK increase.
halfpenny
15/8/2022
14:51
Next stop 1600
netcurtains
15/8/2022
14:40
GSK still risky any bid would be at 800 so be patient and further falls will be dramatic once we get to legal cases starting end August. Claims are now ramping up at record pace with more Lawyers involved !!!
halfpenny
15/8/2022
14:14
Good posts wallywoo,my sentiments exactly.Post xd date this could drop lower due to time of year and low volume trade volatility but after selling pre demerger i have profits from GSK to cushion any share price drops....within reason that is!
redbaron10
15/8/2022
14:11
Litigation uncertainty has been around since 2019. Not stopped the share price trotting back to 1800+.

As I say, doubt very much it is a BP oil spill scenario.

wallywoo
15/8/2022
14:06
Hmmm, I doubt any company would want to buy GSK given the litigation uncertainty (Bayer/Monsanto?!), unless of course it is another company listed as a defendant eg Pfizer or Sanofi!
spyder
15/8/2022
13:58
Personally think this is the market targeting GSK for a bear raid. They are freshly demerged, so are vulnerable to more volatility. Being August also makes now a good time to hit the shares with many being away from their trading desk. There is always a law suit going on with these companies, just part of normal business. Zantac is not another BP oil spill scenario imo.


Once that all settles down GSK will go back to being a nice defensive play in difficult times.


It could of course, attract a bid at these prices too. So a share price recovery could happen very quickly.

wallywoo
15/8/2022
13:25
It's all about TRUST - and the market doesn't for some reason
jonjoneil
15/8/2022
13:16
Yes they have to put a PR stunt...let the market decide...or those in the know...
diku
15/8/2022
13:05
Let's hope soTbh - I doubt whether the rns would have ever admitted there was a problem
watfordhornet
15/8/2022
12:56
The recent RNS clearly states no case to answer. If so we (GSK and HLN) are at bargain prices.
pcok
15/8/2022
12:46
My latest worry is that GSK will soon face multiple class action suits for violation of securities laws relating to this whole debacle.
This is all pretty dreadful and I think anyone who bought Haleon post IPO but before this news broke would have pretty good reason to feel seriously aggrieved.
The Board must be starting to feel a bit anxious.

spyder
15/8/2022
12:31
Looks bang on the money sorry longs

halfpenny15 Aug '22 - 10:51 - 30563 of 30572

chesty1
15/8/2022
12:29
My biggest investment mistake (by a wide margin!) has been sticking with GSK over the last 35 years rather than AZN. Big mistake, huge …
spyder
15/8/2022
12:23
xd this thurs. could see £13 after.
unastubbs
15/8/2022
11:26
halfpenny
'You need a smart knowledgeable CEO/Captain to gain respect and trust'

Totally agree with that statement, but good CEO's of pharmaceutical companies are as impossible to find as competent politicians

jonjoneil
15/8/2022
11:09
.... or wet soap.
jonjoneil
Chat Pages: Latest  1244  1243  1242  1241  1240  1239  1238  1237  1236  1235  1234  1233  Older

Your Recent History

Delayed Upgrade Clock